Laryngeal neoplasms
Clinical trials for Laryngeal neoplasms explained in plain language.
Never miss a new study
Get alerted when new Laryngeal neoplasms trials appear
Sign up with your email to follow new studies for Laryngeal neoplasms, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could existing cancer drugs tackle rare tumors? new trial aims to find out
Disease control Recruiting nowThis trial tests whether two approved drugs, dabrafenib and trametinib, can treat rare cancers that have a specific genetic change called BRAF V600. These drugs are already used for melanoma and lung cancer, but researchers want to see if they help people with other cancer types.…
Matched conditions: LARYNGEAL NEOPLASMS
Phase 2/3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a melanoma drug combo tame rare BRAF cancers?
Disease control Recruiting nowThis trial is testing two drugs, vemurafenib and cobimetinib, already approved for melanoma, in adults with other rare cancers that have a specific genetic change called BRAF V600 mutation. The goal is to see if the combination can shrink tumors or stop them from growing. About 3…
Matched conditions: LARYNGEAL NEOPLASMS
Phase 2/3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC